January 2018 Oncology

Clinical Pharmcology Update: Tremfya

January 22, 2018

Rx Product News Profile

The FDA has approved Tremfya (guselkumab, Janssen Biotech, Inc) for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.